SteelPeak Wealth’s Idexx Laboratories IDXX Stock Holding History

SteelPeak Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-414	Closed	-$257K	–	446
2021 Q3	$257K	Buy	+414	New	+$278K	0.02%	354

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SteelPeak Wealth's IDXX Position: Q4 2021 in Review

SteelPeak Wealth sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 414 shares — an estimated $257K sold.

SteelPeak Wealth first reported a position in IDXX in Q3 2021 and held it in 1 quarter. The position peaked at $257K in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

SteelPeak Wealth reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
SteelPeak Wealth sold 414 Idexx Laboratories shares in Q4 2021, an estimated $257K.
SteelPeak Wealth first reported a position in Idexx Laboratories in Q3 2021 and held it in 1 quarter.
SteelPeak Wealth's Idexx Laboratories position peaked at $257K in Q3 2021.
1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on SteelPeak Wealth's 13F filing for Q4 2021, filed 31 Jan 2022.